<SEC-DOCUMENT>0001140361-23-012381.txt : 20230320
<SEC-HEADER>0001140361-23-012381.hdr.sgml : 20230320
<ACCEPTANCE-DATETIME>20230317175652
ACCESSION NUMBER:		0001140361-23-012381
CONFORMED SUBMISSION TYPE:	SC 13D/A
PUBLIC DOCUMENT COUNT:		1
FILED AS OF DATE:		20230320
DATE AS OF CHANGE:		20230317

SUBJECT COMPANY:	

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			Skye Bioscience, Inc.
		CENTRAL INDEX KEY:			0001516551
		STANDARD INDUSTRIAL CLASSIFICATION:	PHARMACEUTICAL PREPARATIONS [2834]
		IRS NUMBER:				450692882
		STATE OF INCORPORATION:			NV
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		SC 13D/A
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	005-87830
		FILM NUMBER:		23744125

	BUSINESS ADDRESS:	
		STREET 1:		11250 EL CAMINO REAL, SUITE 100
		CITY:			SAN DIEGO
		STATE:			CA
		ZIP:			92130
		BUSINESS PHONE:		(858) 410-0266

	MAIL ADDRESS:	
		STREET 1:		11250 EL CAMINO REAL, SUITE 100
		CITY:			SAN DIEGO
		STATE:			CA
		ZIP:			92130

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	Emerald Bioscience, Inc.
		DATE OF NAME CHANGE:	20190325

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	Nemus Bioscience, Inc.
		DATE OF NAME CHANGE:	20141030

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	LOAD GUARD LOGISTICS, INC.
		DATE OF NAME CHANGE:	20121107

FILED BY:		

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			Emerald Health Sciences Inc.
		CENTRAL INDEX KEY:			0001728413
		IRS NUMBER:				000000000
		STATE OF INCORPORATION:			A1
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		SC 13D/A

	BUSINESS ADDRESS:	
		STREET 1:		OFFICE 8262
		STREET 2:		THE LANDING, 200-375 WATER ST.
		CITY:			VANCOUVER
		STATE:			A1
		ZIP:			V6B 0M9
		BUSINESS PHONE:		858-361-4499

	MAIL ADDRESS:	
		STREET 1:		OFFICE 8262
		STREET 2:		THE LANDING, 200-375 WATER ST.
		CITY:			VANCOUVER
		STATE:			A1
		ZIP:			V6B 0M9
</SEC-HEADER>
<DOCUMENT>
<TYPE>SC 13D/A
<SEQUENCE>1
<FILENAME>brhc10049877_sc13da.htm
<DESCRIPTION>SC 13D/A
<TEXT>
<html>
  <head>
    <title></title>
    <!-- Licensed to: Broadridge Financial Solutions, LLC
         Document created using Broadridge PROfile 23.2.1.5134
         Copyright 1995 - 2023 Broadridge -->
  </head>
<body bgcolor="#ffffff" style="font-family: 'Times New Roman'; font-size: 10pt; text-align: left; color: #000000;">
  <div>
    <hr align="center" style="border: none; border-bottom: 1px solid black; border-top: 4px solid black; height: 10px; color: #ffffff; background-color: #ffffff; text-align: center; margin-left: auto; margin-right: auto;">
    <div>
      <div style="text-align: center; margin-right: 0.35pt; margin-left: 0.35pt; font-size: 14pt; font-weight: bold;">SECURITIES AND EXCHANGE COMMISSION</div>
      <div style="text-align: center; font-size: 12pt; font-weight: bold;">Washington, D.C. 20549</div>
      <div style="text-align: justify;"> <br>
      </div>
      <div style="text-align: center; font-size: 18pt; font-weight: bold;">SCHEDULE 13D</div>
      <div style="text-align: center; margin-right: 0.35pt; margin-left: 0.35pt; font-weight: bold;">Under the Securities Exchange Act of 1934</div>
      <div style="text-align: center; font-weight: bold;">(Amendment No. 8)*</div>
      <div style="text-align: justify;"> <br>
      </div>
      <table cellspacing="0" cellpadding="0" id="zcf6888df33814a6b80e3c817bb5cc9c7" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; border-collapse: collapse; text-align: left; color: rgb(0, 0, 0);">

          <tr>
            <td style="width: 100%; vertical-align: middle; border-bottom: 2px solid rgb(0, 0, 0); font-size: 24pt;">
              <div style="text-align: center; color: rgb(0, 0, 0); font-weight: bold;">Skye Bioscience, Inc.</div>
            </td>
          </tr>
          <tr>
            <td style="width: 100%; vertical-align: middle;">
              <div style="text-align: center; color: rgb(0, 0, 0);">(Name of Issuer)</div>
            </td>
          </tr>

      </table>
      <div style="text-align: justify;"> <br>
      </div>
      <div style="text-align: center; font-weight: bold;"><u>Common Stock, $0.001 par value</u></div>
      <div style="text-align: center;">(Title of Class of Securities)</div>
      <div style="text-align: center;"> <br>
      </div>
      <div style="text-align: center; font-weight: bold;"><u>29102Y101</u></div>
      <div style="text-align: center;">(CUSIP Number)</div>
      <div style="text-align: justify;"> <br>
      </div>
      <div style="text-align: center; font-weight: bold;">Emerald Health Sciences Inc.</div>
      <div style="color: rgb(0, 0, 0); font-weight: bold;">
        <div style="text-align: center; color: rgb(0, 0, 0);">10th Floor, 595 Howe St., Vancouver, BC V6C 2T5, Canada</div>
      </div>
      <div style="text-align: center; font-weight: bold;"><u>+1-778-868-1582</u></div>
      <div style="text-align: center; margin-right: 0.35pt; margin-left: 0.35pt;">(Name, Address, and Telephone Number of Person Authorized</div>
      <div style="text-align: center;">to Receive Notices and Communications)</div>
      <div style="text-align: justify;"> <br>
      </div>
      <div style="text-align: center;">With a copy to:</div>
      <div style="text-align: center; margin-right: 0.35pt; margin-left: 0.35pt; font-weight: bold;">Jason K. Brenkert</div>
      <div style="text-align: center; margin-right: 0.35pt; margin-left: 0.35pt; font-weight: bold;">Dorsey &amp; Whitney LLP</div>
      <div style="text-align: center; margin-right: 0.35pt; margin-left: 0.35pt; font-weight: bold;">1400 Wewatta Street, Suite 400</div>
      <div style="text-align: center; margin-right: 0.35pt; margin-left: 0.35pt; font-weight: bold;">Denver, Colorado 80202-5549</div>
      <div style="text-align: center; font-weight: bold;">(303) 629-3445</div>
      <div><br>
      </div>
      <div style="text-align: center; font-weight: bold;"><u>February 23, 2023</u></div>
      <div style="text-align: center;">(Date of Event which Requires Filing of this Statement)</div>
      <div style="text-align: center;"> <br>
      </div>
      <div style="text-align: justify;">If the filing person has previously filed a statement on Schedule 13G to report the acquisition that is the subject of this Schedule 13D, and is filing this schedule because of Rule 13d-1(e), Rule 13d-1(f) or Rule
        13d-1(g), check the following box. &#9744;</div>
      <div style="text-align: justify;"> <br>
      </div>
      <div style="text-align: justify;"><font style="font-style: italic;">Note</font>:<font style="font-style: italic;">&#160;</font>Schedules filed in paper format shall include a signed original and five copies of the schedule, including all exhibits. <font style="font-style: italic;">See</font> Rule 13d-7 for other parties to whom copies are to be sent.</div>
      <div style="text-align: justify;"> <br>
        <div>
          <table cellspacing="0" cellpadding="0" id="ze9a87b854d4744668f233d5893a496d0" class="DSPFListTable" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: rgb(0, 0, 0);">

              <tr>
                <td style="width: 9pt; vertical-align: top; text-align: right;">
                  <div style="text-align: left; color: rgb(0, 0, 0);">*</div>
                </td>
                <td style="width: auto; vertical-align: top;">
                  <div style="color: rgb(0, 0, 0);">The remainder of this cover page shall be filled out for a reporting person&#8217;s initial filing on this form with respect to the subject class of securities, and for any subsequent amendment containing
                    information which would alter disclosures provided in a prior cover page.</div>
                </td>
              </tr>

          </table>
        </div>
      </div>
    </div>
    <div><br>
      <div style="text-align: justify;">The information required on the remainder of this cover page shall not be deemed to be &#8220;filed&#8221; for the purpose of Section 18 of the Securities Exchange Act of 1934 (&#8220;Act&#8221;) or otherwise subject to the liabilities of
        that section of the Act but shall be subject to all other provisions of the Act (however, see the Notes).</div>
      <div style="text-align: justify;"> <br>
      </div>
      <div>
        <hr align="center" style="border: none; border-bottom: 4px solid black; border-top: 1px solid black; height: 10px; color: #ffffff; background-color: #ffffff; text-align: center; margin-left: auto; margin-right: auto;"></div>
      <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="BRPFPageBreakArea">
        <div style="page-break-after: always;" class="BRPFPageBreak">
          <hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px 0px; width: 100%; height: 2px; color: #000000; background-color: #000000;"></div>
        <div style="width: 100%;" class="BRPFPageHeader">
          <div>
            <table cellspacing="0" cellpadding="0" border="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; border-collapse: collapse; text-align: left; color: #000000;">

                <tr>
                  <td style="width: 40%; vertical-align: middle; border-width: 2px; border-style: solid; border-color: rgb(0, 0, 0);">
                    <div style="text-align: center; color: #000000; font-weight: bold;">CUSIP No. 29102Y101</div>
                  </td>
                  <td style="width: 40%; vertical-align: middle; padding-bottom: 2px;">
                    <div style="text-align: justify; color: #000000;">&#160;</div>
                  </td>
                  <td style="width: 20%; vertical-align: middle; padding-bottom: 2px;">
                    <div style="color: rgb(0, 0, 0); font-weight: bold;">Page <font class="BRPFPageNumber">2</font> of 6<br>
                    </div>
                  </td>
                </tr>

            </table>
          </div>
        </div>
      </div>
      <table cellspacing="0" cellpadding="2" border="0" style="border-collapse: collapse; width: 100%; font-family: 'Times New Roman'; font-size: 10pt;">

          <tr>
            <td rowspan="3" style="BORDER-TOP: #000000 1pt solid; VERTICAL-ALIGN: middle; BORDER-BOTTOM: #000000 1pt solid; BORDER-LEFT: #000000 1pt solid; WIDTH: 6.36%">
              <div style="FONT-SIZE: 18pt; FONT-WEIGHT: bold; TEXT-ALIGN: center">1</div>
            </td>
            <td colspan="3" style="BORDER-TOP: #000000 1pt solid; VERTICAL-ALIGN: middle; BORDER-LEFT: #000000 1pt solid; WIDTH: 86.4%">
              <div style="FONT-WEIGHT: bold; TEXT-ALIGN: left">NAMES OF REPORTING PERSONS</div>
            </td>
            <td style="BORDER-TOP: #000000 1pt solid; VERTICAL-ALIGN: middle; WIDTH: 2.59%">
              <div style="TEXT-ALIGN: left">&#160;</div>
            </td>
            <td style="BORDER-TOP: #000000 1pt solid; BORDER-RIGHT: #000000 1pt solid; VERTICAL-ALIGN: top; WIDTH: 5.01%">
              <div style="TEXT-ALIGN: left">&#160;</div>
            </td>
          </tr>
          <tr>
            <td colspan="3" rowspan="2" style="VERTICAL-ALIGN: middle; BORDER-BOTTOM: #000000 1pt solid; PADDING-LEFT: 2pt; BORDER-LEFT: #000000 1pt solid; WIDTH: 86.4%">
              <div style="TEXT-ALIGN: left">
                <div style="text-align: justify; color: #000000; font-weight: bold;">Emerald Health Sciences Inc.</div>
              </div>
            </td>
            <td style="VERTICAL-ALIGN: middle; WIDTH: 2.59%">
              <div style="TEXT-ALIGN: left">&#160;</div>
            </td>
            <td style="BORDER-RIGHT: #000000 1pt solid; VERTICAL-ALIGN: top; WIDTH: 5.01%">
              <div style="TEXT-ALIGN: left">&#160;</div>
            </td>
          </tr>
          <tr>
            <td style="VERTICAL-ALIGN: middle; BORDER-BOTTOM: #000000 1pt solid; WIDTH: 2.59%">
              <div style="TEXT-ALIGN: left">&#160;</div>
            </td>
            <td style="BORDER-RIGHT: #000000 1pt solid; VERTICAL-ALIGN: top; BORDER-BOTTOM: #000000 1pt solid; WIDTH: 5.01%">
              <div style="TEXT-ALIGN: left">&#160;</div>
            </td>
          </tr>
          <tr style="HEIGHT: 13px">
            <td rowspan="3" style="VERTICAL-ALIGN: middle; BORDER-BOTTOM: #000000 1pt solid; BORDER-LEFT: #000000 1pt solid; WIDTH: 6.36%">
              <div style="FONT-SIZE: 18pt; FONT-WEIGHT: bold; TEXT-ALIGN: center">2</div>
            </td>
            <td colspan="3" style="VERTICAL-ALIGN: middle; BORDER-LEFT: #000000 1pt solid; WIDTH: 86.4%">
              <div style="FONT-WEIGHT: bold; TEXT-ALIGN: left">CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP</div>
            </td>
            <td style="VERTICAL-ALIGN: middle; WIDTH: 2.59%">
              <div style="TEXT-ALIGN: right">(a)</div>
            </td>
            <td style="BORDER-RIGHT: #000000 1pt solid; VERTICAL-ALIGN: middle; PADDING-RIGHT: 2px; WIDTH: 5.01%">
              <div style="FONT-FAMILY: ''Times New Roman''; TEXT-ALIGN: left">&#9744;</div>
            </td>
          </tr>
          <tr>
            <td colspan="3" rowspan="2" style="VERTICAL-ALIGN: middle; BORDER-BOTTOM: #000000 1pt solid; BORDER-LEFT: #000000 1pt solid; WIDTH: 86.4%">&#160;</td>
            <td style="VERTICAL-ALIGN: middle; WIDTH: 2.59%">
              <div style="TEXT-ALIGN: right">(b)</div>
            </td>
            <td style="BORDER-RIGHT: #000000 1pt solid; VERTICAL-ALIGN: middle; PADDING-RIGHT: 2px; WIDTH: 5.01%">
              <div style="FONT-FAMILY: ''Times New Roman''; TEXT-ALIGN: left">&#9744;</div>
            </td>
          </tr>
          <tr>
            <td style="VERTICAL-ALIGN: middle; BORDER-BOTTOM: #000000 1pt solid; WIDTH: 2.59%">
              <div style="TEXT-ALIGN: left">&#160;</div>
            </td>
            <td style="BORDER-RIGHT: #000000 1pt solid; VERTICAL-ALIGN: top; BORDER-BOTTOM: #000000 1pt solid; WIDTH: 5.01%">
              <div style="TEXT-ALIGN: left">&#160;</div>
            </td>
          </tr>
          <tr>
            <td rowspan="3" style="VERTICAL-ALIGN: middle; BORDER-BOTTOM: #000000 1pt solid; BORDER-LEFT: #000000 1pt solid; WIDTH: 6.36%">
              <div style="FONT-SIZE: 18pt; FONT-WEIGHT: bold; TEXT-ALIGN: center">3</div>
            </td>
            <td colspan="3" style="VERTICAL-ALIGN: middle; BORDER-LEFT: #000000 1pt solid; WIDTH: 86.4%; BACKGROUND-COLOR: #bfbfbf">
              <div style="FONT-WEIGHT: bold; TEXT-ALIGN: left">SEC USE ONLY</div>
            </td>
            <td style="VERTICAL-ALIGN: middle; WIDTH: 2.59%; BACKGROUND-COLOR: #bfbfbf">
              <div style="TEXT-ALIGN: left">&#160;</div>
            </td>
            <td style="BORDER-RIGHT: #000000 1pt solid; VERTICAL-ALIGN: top; WIDTH: 5.01%; BACKGROUND-COLOR: #bfbfbf">
              <div style="TEXT-ALIGN: left">&#160;</div>
            </td>
          </tr>
          <tr style="BACKGROUND-COLOR: #bfbfbf">
            <td colspan="3" rowspan="2" style="VERTICAL-ALIGN: middle; BORDER-BOTTOM: #000000 1pt solid; BORDER-LEFT: #000000 1pt solid; WIDTH: 86.4%">
              <div style="TEXT-ALIGN: left">&#160;</div>
            </td>
            <td style="VERTICAL-ALIGN: middle; WIDTH: 2.59%">
              <div style="TEXT-ALIGN: left">&#160;</div>
            </td>
            <td style="BORDER-RIGHT: #000000 1pt solid; VERTICAL-ALIGN: top; WIDTH: 5.01%">
              <div style="TEXT-ALIGN: left">&#160;</div>
            </td>
          </tr>
          <tr style="BACKGROUND-COLOR: #bfbfbf">
            <td style="VERTICAL-ALIGN: middle; BORDER-BOTTOM: #000000 1pt solid; WIDTH: 2.59%">
              <div style="TEXT-ALIGN: left">&#160;</div>
            </td>
            <td style="BORDER-RIGHT: #000000 1pt solid; VERTICAL-ALIGN: top; BORDER-BOTTOM: #000000 1pt solid; WIDTH: 5.01%">
              <div style="TEXT-ALIGN: left">&#160;</div>
            </td>
          </tr>
          <tr>
            <td rowspan="3" style="VERTICAL-ALIGN: middle; BORDER-BOTTOM: #000000 1pt solid; BORDER-LEFT: #000000 1pt solid; WIDTH: 6.36%">
              <div style="FONT-SIZE: 18pt; FONT-WEIGHT: bold; TEXT-ALIGN: center">4</div>
            </td>
            <td colspan="3" style="VERTICAL-ALIGN: middle; BORDER-LEFT: #000000 1pt solid; WIDTH: 86.4%">
              <div style="FONT-WEIGHT: bold; TEXT-ALIGN: left">SOURCE OF FUNDS (SEE INSTRUCTIONS)</div>
            </td>
            <td style="VERTICAL-ALIGN: middle; WIDTH: 2.59%">
              <div style="TEXT-ALIGN: left">&#160;</div>
            </td>
            <td style="BORDER-RIGHT: #000000 1pt solid; VERTICAL-ALIGN: top; WIDTH: 5.01%">
              <div style="TEXT-ALIGN: left">&#160;</div>
            </td>
          </tr>
          <tr>
            <td colspan="3" rowspan="2" style="VERTICAL-ALIGN: middle; BORDER-BOTTOM: #000000 1pt solid; PADDING-LEFT: 2pt; BORDER-LEFT: #000000 1pt solid; WIDTH: 86.4%">
              <div style="TEXT-ALIGN: left">
                <div style="text-align: justify; color: #000000; font-weight: bold;">WC, OO</div>
              </div>
            </td>
            <td style="VERTICAL-ALIGN: middle; WIDTH: 2.59%">
              <div style="TEXT-ALIGN: left">&#160;</div>
            </td>
            <td style="BORDER-RIGHT: #000000 1pt solid; VERTICAL-ALIGN: top; WIDTH: 5.01%">
              <div style="TEXT-ALIGN: left">&#160;</div>
            </td>
          </tr>
          <tr>
            <td style="VERTICAL-ALIGN: middle; BORDER-BOTTOM: #000000 1pt solid; WIDTH: 2.59%">
              <div style="TEXT-ALIGN: left">&#160;</div>
            </td>
            <td style="BORDER-RIGHT: #000000 1pt solid; VERTICAL-ALIGN: top; BORDER-BOTTOM: #000000 1pt solid; WIDTH: 5.01%">
              <div style="TEXT-ALIGN: left">&#160;</div>
            </td>
          </tr>
          <tr>
            <td rowspan="3" style="VERTICAL-ALIGN: middle; BORDER-BOTTOM: #000000 1pt solid; BORDER-LEFT: #000000 1pt solid; WIDTH: 6.36%">
              <div style="FONT-SIZE: 18pt; FONT-WEIGHT: bold; TEXT-ALIGN: center">5</div>
            </td>
            <td colspan="3" style="VERTICAL-ALIGN: middle; BORDER-LEFT: #000000 1pt solid; WIDTH: 86.4%">
              <div style="FONT-WEIGHT: bold; TEXT-ALIGN: left">CHECK BOX IF DISCLOSURE OF LEGAL PROCEEDINGS IS REQUIRED PURSUANT TO ITEM 2(D) OR 2(E)</div>
            </td>
            <td style="VERTICAL-ALIGN: middle; WIDTH: 2.59%">
              <div style="TEXT-ALIGN: left">&#160;</div>
            </td>
            <td style="BORDER-RIGHT: #000000 1pt solid; VERTICAL-ALIGN: middle; PADDING-RIGHT: 2px; WIDTH: 5.01%">
              <div style="FONT-FAMILY: ''Times New Roman''; TEXT-ALIGN: left">&#9744;</div>
            </td>
          </tr>
          <tr>
            <td colspan="3" rowspan="2" style="VERTICAL-ALIGN: middle; BORDER-BOTTOM: #000000 1pt solid; BORDER-LEFT: #000000 1pt solid; WIDTH: 86.4%">&#160;</td>
            <td style="VERTICAL-ALIGN: middle; WIDTH: 2.59%">
              <div style="TEXT-ALIGN: left">&#160;</div>
            </td>
            <td style="BORDER-RIGHT: #000000 1pt solid; VERTICAL-ALIGN: top; WIDTH: 5.01%">
              <div style="TEXT-ALIGN: left">&#160;</div>
            </td>
          </tr>
          <tr>
            <td style="VERTICAL-ALIGN: middle; BORDER-BOTTOM: #000000 1pt solid; WIDTH: 2.59%">
              <div style="TEXT-ALIGN: left">&#160;</div>
            </td>
            <td style="BORDER-RIGHT: #000000 1pt solid; VERTICAL-ALIGN: top; BORDER-BOTTOM: #000000 1pt solid; WIDTH: 5.01%">
              <div style="TEXT-ALIGN: left">&#160;</div>
            </td>
          </tr>
          <tr>
            <td rowspan="3" style="VERTICAL-ALIGN: middle; BORDER-BOTTOM: #000000 1pt solid; BORDER-LEFT: #000000 1pt solid; WIDTH: 6.36%">
              <div style="FONT-SIZE: 18pt; FONT-WEIGHT: bold; TEXT-ALIGN: center">6</div>
            </td>
            <td colspan="3" style="VERTICAL-ALIGN: middle; BORDER-LEFT: #000000 1pt solid; WIDTH: 86.4%">
              <div style="FONT-WEIGHT: bold; TEXT-ALIGN: left">CITIZENSHIP OR PLACE OF ORGANIZATION</div>
            </td>
            <td style="VERTICAL-ALIGN: middle; WIDTH: 2.59%">
              <div style="TEXT-ALIGN: left">&#160;</div>
            </td>
            <td style="BORDER-RIGHT: #000000 1pt solid; VERTICAL-ALIGN: top; WIDTH: 5.01%">
              <div style="TEXT-ALIGN: left">&#160;</div>
            </td>
          </tr>
          <tr>
            <td colspan="3" rowspan="2" style="VERTICAL-ALIGN: middle; BORDER-BOTTOM: #000000 1pt solid; PADDING-LEFT: 2pt; BORDER-LEFT: #000000 1pt solid; WIDTH: 86.4%">
              <div style="TEXT-ALIGN: left">
                <div style="text-align: justify; color: #000000; font-weight: bold;">British Columbia, Canada</div>
              </div>
            </td>
            <td style="VERTICAL-ALIGN: middle; WIDTH: 2.59%">
              <div style="TEXT-ALIGN: left">&#160;</div>
            </td>
            <td style="BORDER-RIGHT: #000000 1pt solid; VERTICAL-ALIGN: top; WIDTH: 5.01%">
              <div style="TEXT-ALIGN: left">&#160;</div>
            </td>
          </tr>
          <tr>
            <td style="VERTICAL-ALIGN: middle; BORDER-BOTTOM: #000000 1pt solid; WIDTH: 2.59%">
              <div style="TEXT-ALIGN: left">&#160;</div>
            </td>
            <td style="BORDER-RIGHT: #000000 1pt solid; VERTICAL-ALIGN: top; BORDER-BOTTOM: #000000 1pt solid; WIDTH: 5.01%">
              <div style="TEXT-ALIGN: left">&#160;</div>
            </td>
          </tr>
          <tr>
            <td colspan="2" rowspan="12" style="VERTICAL-ALIGN: middle; BORDER-BOTTOM: #000000 1pt solid; FONT-WEIGHT: bold; BORDER-LEFT: #000000 1pt solid; WIDTH: 12.71%">
              <div style="TEXT-ALIGN: center">NUMBER OF SHARES BENEFICIALLY OWNED BY EACH REPORTING PERSON WITH</div>
            </td>
            <td rowspan="3" style="VERTICAL-ALIGN: middle; BORDER-BOTTOM: #000000 1pt solid; BORDER-LEFT: #000000 1pt solid; WIDTH: 6.36%">
              <div style="FONT-SIZE: 18pt; FONT-WEIGHT: bold; TEXT-ALIGN: center">7</div>
            </td>
            <td style="VERTICAL-ALIGN: middle; BORDER-LEFT: #000000 1pt solid; WIDTH: 76.38%">
              <div style="FONT-WEIGHT: bold; TEXT-ALIGN: left">SOLE VOTING POWER</div>
            </td>
            <td style="VERTICAL-ALIGN: middle; WIDTH: 2.59%">
              <div style="TEXT-ALIGN: left">&#160;</div>
            </td>
            <td style="BORDER-RIGHT: #000000 1pt solid; VERTICAL-ALIGN: top; WIDTH: 5.01%">
              <div style="TEXT-ALIGN: left">&#160;</div>
            </td>
          </tr>
          <tr>
            <td rowspan="2" style="VERTICAL-ALIGN: middle; BORDER-BOTTOM: #000000 1pt solid; PADDING-LEFT: 2pt; BORDER-LEFT: #000000 1pt solid; WIDTH: 76.38%">
              <div style="text-align: left; font-weight: bold;">169,407,901</div>
            </td>
            <td style="VERTICAL-ALIGN: middle; WIDTH: 2.59%">
              <div style="TEXT-ALIGN: left">&#160;</div>
            </td>
            <td style="BORDER-RIGHT: #000000 1pt solid; VERTICAL-ALIGN: top; WIDTH: 5.01%">
              <div style="TEXT-ALIGN: left">&#160;</div>
            </td>
          </tr>
          <tr>
            <td style="VERTICAL-ALIGN: middle; BORDER-BOTTOM: #000000 1pt solid; WIDTH: 2.59%">
              <div style="TEXT-ALIGN: left">&#160;</div>
            </td>
            <td style="BORDER-RIGHT: #000000 1pt solid; VERTICAL-ALIGN: top; BORDER-BOTTOM: #000000 1pt solid; WIDTH: 5.01%">
              <div style="TEXT-ALIGN: left">&#160;</div>
            </td>
          </tr>
          <tr>
            <td rowspan="3" style="VERTICAL-ALIGN: middle; BORDER-BOTTOM: #000000 1pt solid; BORDER-LEFT: #000000 1pt solid; WIDTH: 6.36%">
              <div style="FONT-SIZE: 18pt; FONT-WEIGHT: bold; TEXT-ALIGN: center">8</div>
            </td>
            <td style="VERTICAL-ALIGN: middle; BORDER-LEFT: #000000 1pt solid; WIDTH: 76.38%">
              <div style="FONT-WEIGHT: bold; TEXT-ALIGN: left">SHARED VOTING POWER</div>
            </td>
            <td style="VERTICAL-ALIGN: middle; WIDTH: 2.59%">
              <div style="TEXT-ALIGN: left">&#160;</div>
            </td>
            <td style="BORDER-RIGHT: #000000 1pt solid; VERTICAL-ALIGN: top; WIDTH: 5.01%">
              <div style="TEXT-ALIGN: left">&#160;</div>
            </td>
          </tr>
          <tr>
            <td rowspan="2" style="VERTICAL-ALIGN: middle; BORDER-BOTTOM: #000000 1pt solid; PADDING-LEFT: 2pt; BORDER-LEFT: #000000 1pt solid; WIDTH: 76.38%">
              <div style="TEXT-ALIGN: left">
                <div style="text-align: justify; color: #000000; font-weight: bold;">
                  <div style="color: #000000; font-weight: bold;">0</div>
                </div>
              </div>
            </td>
            <td style="VERTICAL-ALIGN: middle; WIDTH: 2.59%">
              <div style="TEXT-ALIGN: left">&#160;</div>
            </td>
            <td style="BORDER-RIGHT: #000000 1pt solid; VERTICAL-ALIGN: top; WIDTH: 5.01%">
              <div style="TEXT-ALIGN: left">&#160;</div>
            </td>
          </tr>
          <tr>
            <td style="VERTICAL-ALIGN: middle; BORDER-BOTTOM: #000000 1pt solid; WIDTH: 2.59%">
              <div style="TEXT-ALIGN: left">&#160;</div>
            </td>
            <td style="BORDER-RIGHT: #000000 1pt solid; VERTICAL-ALIGN: top; BORDER-BOTTOM: #000000 1pt solid; WIDTH: 5.01%">
              <div style="TEXT-ALIGN: left">&#160;</div>
            </td>
          </tr>
          <tr>
            <td rowspan="3" style="VERTICAL-ALIGN: middle; BORDER-BOTTOM: #000000 1pt solid; BORDER-LEFT: #000000 1pt solid; WIDTH: 6.36%">
              <div style="FONT-SIZE: 18pt; FONT-WEIGHT: bold; TEXT-ALIGN: center">9</div>
            </td>
            <td style="VERTICAL-ALIGN: middle; BORDER-LEFT: #000000 1pt solid; WIDTH: 76.38%">
              <div style="FONT-WEIGHT: bold; TEXT-ALIGN: left">SOLE DISPOSITIVE POWER</div>
            </td>
            <td style="VERTICAL-ALIGN: middle; WIDTH: 2.59%">
              <div style="TEXT-ALIGN: left">&#160;</div>
            </td>
            <td style="BORDER-RIGHT: #000000 1pt solid; VERTICAL-ALIGN: top; WIDTH: 5.01%">
              <div style="TEXT-ALIGN: left">&#160;</div>
            </td>
          </tr>
          <tr>
            <td rowspan="2" style="VERTICAL-ALIGN: middle; BORDER-BOTTOM: #000000 1pt solid; PADDING-LEFT: 2pt; BORDER-LEFT: #000000 1pt solid; WIDTH: 76.38%">
              <div style="TEXT-ALIGN: left">
                <div style="text-align: justify; color: #000000; font-weight: bold;">169,407,901</div>
              </div>
            </td>
            <td style="VERTICAL-ALIGN: middle; WIDTH: 2.59%">
              <div style="TEXT-ALIGN: left">&#160;</div>
            </td>
            <td style="BORDER-RIGHT: #000000 1pt solid; VERTICAL-ALIGN: top; WIDTH: 5.01%">
              <div style="TEXT-ALIGN: left">&#160;</div>
            </td>
          </tr>
          <tr>
            <td style="VERTICAL-ALIGN: middle; BORDER-BOTTOM: #000000 1pt solid; WIDTH: 2.59%">
              <div style="TEXT-ALIGN: left">&#160;</div>
            </td>
            <td style="BORDER-RIGHT: #000000 1pt solid; VERTICAL-ALIGN: top; BORDER-BOTTOM: #000000 1pt solid; WIDTH: 5.01%">
              <div style="TEXT-ALIGN: left">&#160;</div>
            </td>
          </tr>
          <tr>
            <td rowspan="3" style="VERTICAL-ALIGN: middle; BORDER-BOTTOM: #000000 1pt solid; BORDER-LEFT: #000000 1pt solid; WIDTH: 6.36%">
              <div style="FONT-SIZE: 18pt; FONT-WEIGHT: bold; TEXT-ALIGN: center">10</div>
            </td>
            <td style="VERTICAL-ALIGN: middle; BORDER-LEFT: #000000 1pt solid; WIDTH: 76.38%">
              <div style="FONT-WEIGHT: bold; TEXT-ALIGN: left">SHARED DISPOSITIVE POWER</div>
            </td>
            <td style="VERTICAL-ALIGN: middle; WIDTH: 2.59%">
              <div style="TEXT-ALIGN: left">&#160;</div>
            </td>
            <td style="BORDER-RIGHT: #000000 1pt solid; VERTICAL-ALIGN: top; WIDTH: 5.01%">
              <div style="TEXT-ALIGN: left">&#160;</div>
            </td>
          </tr>
          <tr>
            <td rowspan="2" style="VERTICAL-ALIGN: middle; BORDER-BOTTOM: #000000 1pt solid; PADDING-LEFT: 2pt; BORDER-LEFT: #000000 1pt solid; WIDTH: 76.38%">
              <div style="TEXT-ALIGN: left">
                <div style="text-align: justify; color: #000000; font-weight: bold;">0</div>
              </div>
            </td>
            <td style="VERTICAL-ALIGN: middle; WIDTH: 2.59%">
              <div style="TEXT-ALIGN: left">&#160;</div>
            </td>
            <td style="BORDER-RIGHT: #000000 1pt solid; VERTICAL-ALIGN: top; WIDTH: 5.01%">
              <div style="TEXT-ALIGN: left">&#160;</div>
            </td>
          </tr>
          <tr>
            <td style="VERTICAL-ALIGN: middle; BORDER-BOTTOM: #000000 1pt solid; WIDTH: 2.59%">
              <div style="TEXT-ALIGN: left">&#160;</div>
            </td>
            <td style="BORDER-RIGHT: #000000 1pt solid; VERTICAL-ALIGN: top; BORDER-BOTTOM: #000000 1pt solid; WIDTH: 5.01%">
              <div style="TEXT-ALIGN: left">&#160;</div>
            </td>
          </tr>
          <tr>
            <td rowspan="3" style="VERTICAL-ALIGN: middle; BORDER-BOTTOM: #000000 1pt solid; BORDER-LEFT: #000000 1pt solid; WIDTH: 6.36%">
              <div style="FONT-SIZE: 18pt; FONT-WEIGHT: bold; TEXT-ALIGN: center">11</div>
            </td>
            <td colspan="3" style="VERTICAL-ALIGN: middle; BORDER-LEFT: #000000 1pt solid; WIDTH: 86.4%">
              <div style="FONT-WEIGHT: bold; TEXT-ALIGN: left">AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON</div>
            </td>
            <td style="VERTICAL-ALIGN: middle; WIDTH: 2.59%">
              <div style="TEXT-ALIGN: left">&#160;</div>
            </td>
            <td style="BORDER-RIGHT: #000000 1pt solid; VERTICAL-ALIGN: top; WIDTH: 5.01%">
              <div style="TEXT-ALIGN: left">&#160;</div>
            </td>
          </tr>
          <tr>
            <td colspan="3" rowspan="2" style="VERTICAL-ALIGN: middle; BORDER-BOTTOM: #000000 1pt solid; PADDING-LEFT: 2pt; BORDER-LEFT: #000000 1pt solid; WIDTH: 86.4%">
              <div style="TEXT-ALIGN: left">
                <div style="text-align: justify; color: #000000; font-weight: bold;">169,407,901</div>
              </div>
            </td>
            <td style="VERTICAL-ALIGN: middle; WIDTH: 2.59%">
              <div style="TEXT-ALIGN: left">&#160;</div>
            </td>
            <td style="BORDER-RIGHT: #000000 1pt solid; VERTICAL-ALIGN: top; WIDTH: 5.01%">
              <div style="TEXT-ALIGN: left">&#160;</div>
            </td>
          </tr>
          <tr>
            <td style="VERTICAL-ALIGN: middle; BORDER-BOTTOM: #000000 1pt solid; WIDTH: 2.59%">
              <div style="TEXT-ALIGN: left">&#160;</div>
            </td>
            <td style="BORDER-RIGHT: #000000 1pt solid; VERTICAL-ALIGN: top; BORDER-BOTTOM: #000000 1pt solid; WIDTH: 5.01%">
              <div style="TEXT-ALIGN: left">&#160;</div>
            </td>
          </tr>
          <tr>
            <td rowspan="3" style="VERTICAL-ALIGN: middle; BORDER-BOTTOM: #000000 1pt solid; BORDER-LEFT: #000000 1pt solid; WIDTH: 6.36%">
              <div style="FONT-SIZE: 18pt; FONT-WEIGHT: bold; TEXT-ALIGN: center">12</div>
            </td>
            <td colspan="3" style="VERTICAL-ALIGN: middle; BORDER-LEFT: #000000 1pt solid; WIDTH: 86.4%">
              <div style="FONT-WEIGHT: bold; TEXT-ALIGN: left">CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (11) EXCLUDES CERTAIN SHARES (SEE INSTRUCTIONS)</div>
            </td>
            <td style="VERTICAL-ALIGN: middle; WIDTH: 2.59%">
              <div style="TEXT-ALIGN: left">&#160;</div>
            </td>
            <td style="BORDER-RIGHT: #000000 1pt solid; VERTICAL-ALIGN: middle; PADDING-RIGHT: 2px; WIDTH: 5.01%">
              <div style="FONT-FAMILY: ''Times New Roman''; TEXT-ALIGN: left">&#9744;</div>
            </td>
          </tr>
          <tr>
            <td colspan="3" rowspan="2" style="VERTICAL-ALIGN: middle; BORDER-BOTTOM: #000000 1pt solid; BORDER-LEFT: #000000 1pt solid; WIDTH: 86.4%">&#160;</td>
            <td style="VERTICAL-ALIGN: middle; WIDTH: 2.59%">
              <div style="TEXT-ALIGN: left">&#160;</div>
            </td>
            <td style="BORDER-RIGHT: #000000 1pt solid; VERTICAL-ALIGN: top; WIDTH: 5.01%">
              <div style="TEXT-ALIGN: left">&#160;</div>
            </td>
          </tr>
          <tr>
            <td style="VERTICAL-ALIGN: middle; BORDER-BOTTOM: #000000 1pt solid; WIDTH: 2.59%">
              <div style="TEXT-ALIGN: left">&#160;</div>
            </td>
            <td style="BORDER-RIGHT: #000000 1pt solid; VERTICAL-ALIGN: top; BORDER-BOTTOM: #000000 1pt solid; WIDTH: 5.01%">
              <div style="TEXT-ALIGN: left">&#160;</div>
            </td>
          </tr>
          <tr>
            <td rowspan="3" style="VERTICAL-ALIGN: middle; BORDER-BOTTOM: #000000 1pt solid; BORDER-LEFT: #000000 1pt solid; WIDTH: 6.36%">
              <div style="FONT-SIZE: 18pt; FONT-WEIGHT: bold; TEXT-ALIGN: center">13</div>
            </td>
            <td colspan="3" style="VERTICAL-ALIGN: middle; BORDER-LEFT: #000000 1pt solid; WIDTH: 86.4%">
              <div style="FONT-WEIGHT: bold; TEXT-ALIGN: left">PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (11)</div>
            </td>
            <td style="VERTICAL-ALIGN: middle; WIDTH: 2.59%">
              <div style="TEXT-ALIGN: left">&#160;</div>
            </td>
            <td style="BORDER-RIGHT: #000000 1pt solid; VERTICAL-ALIGN: top; WIDTH: 5.01%">
              <div style="TEXT-ALIGN: left">&#160;</div>
            </td>
          </tr>
          <tr>
            <td colspan="3" rowspan="2" style="VERTICAL-ALIGN: middle; BORDER-BOTTOM: #000000 1pt solid; PADDING-LEFT: 2pt; BORDER-LEFT: #000000 1pt solid; WIDTH: 86.4%">
              <div style="TEXT-ALIGN: left">
                <div style="text-align: justify; color: #000000; font-weight: bold;">17.4% (1)</div>
              </div>
            </td>
            <td style="VERTICAL-ALIGN: middle; WIDTH: 2.59%">
              <div style="TEXT-ALIGN: left">&#160;</div>
            </td>
            <td style="BORDER-RIGHT: #000000 1pt solid; VERTICAL-ALIGN: top; WIDTH: 5.01%">
              <div style="TEXT-ALIGN: left">&#160;</div>
            </td>
          </tr>
          <tr>
            <td style="VERTICAL-ALIGN: middle; BORDER-BOTTOM: #000000 1pt solid; WIDTH: 2.59%">
              <div style="TEXT-ALIGN: left">&#160;</div>
            </td>
            <td style="BORDER-RIGHT: #000000 1pt solid; VERTICAL-ALIGN: top; BORDER-BOTTOM: #000000 1pt solid; WIDTH: 5.01%">
              <div style="TEXT-ALIGN: left">&#160;</div>
            </td>
          </tr>
          <tr>
            <td rowspan="3" style="VERTICAL-ALIGN: middle; BORDER-BOTTOM: #000000 1pt solid; BORDER-LEFT: #000000 1pt solid; WIDTH: 6.36%">
              <div style="FONT-SIZE: 18pt; FONT-WEIGHT: bold; TEXT-ALIGN: center">14</div>
            </td>
            <td colspan="3" style="VERTICAL-ALIGN: middle; BORDER-LEFT: #000000 1pt solid; WIDTH: 86.4%">
              <div style="FONT-WEIGHT: bold; TEXT-ALIGN: left">TYPE OF REPORTING PERSON (SEE INSTRUCTIONS)</div>
            </td>
            <td style="VERTICAL-ALIGN: middle; WIDTH: 2.59%">
              <div style="TEXT-ALIGN: left">&#160;</div>
            </td>
            <td style="BORDER-RIGHT: #000000 1pt solid; VERTICAL-ALIGN: top; WIDTH: 5.01%">
              <div style="TEXT-ALIGN: left">&#160;</div>
            </td>
          </tr>
          <tr>
            <td colspan="3" rowspan="2" style="VERTICAL-ALIGN: middle; BORDER-BOTTOM: #000000 1pt solid; PADDING-LEFT: 2pt; BORDER-LEFT: #000000 1pt solid; WIDTH: 86.4%">
              <div style="TEXT-ALIGN: left">
                <div style="text-align: justify; color: #000000; font-weight: bold;">CO</div>
              </div>
            </td>
            <td style="VERTICAL-ALIGN: middle; WIDTH: 2.59%">
              <div style="TEXT-ALIGN: left">&#160;</div>
            </td>
            <td style="BORDER-RIGHT: #000000 1pt solid; VERTICAL-ALIGN: top; WIDTH: 5.01%">
              <div style="TEXT-ALIGN: left">&#160;</div>
            </td>
          </tr>
          <tr>
            <td style="VERTICAL-ALIGN: middle; BORDER-BOTTOM: #000000 1pt solid; WIDTH: 2.59%">
              <div style="TEXT-ALIGN: left">&#160;</div>
            </td>
            <td style="BORDER-RIGHT: #000000 1pt solid; VERTICAL-ALIGN: top; BORDER-BOTTOM: #000000 1pt solid; WIDTH: 5.01%">
              <div style="TEXT-ALIGN: left">&#160;</div>
            </td>
          </tr>

      </table>
      <div style="text-align: justify;"> <br>
      </div>
      <div>
        <div>
          <table cellspacing="0" cellpadding="0" id="z9fbd6ef1b87f4510a6d72519f4d878bd" class="DSPFListTable" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

              <tr>
                <td style="width: 18pt; vertical-align: top; text-align: right;">
                  <div style="text-align: left; color: #000000;">(1)</div>
                </td>
                <td style="width: auto; vertical-align: top;">
                  <div style="color: #000000;">Based on (i) 971,549,608 shares of Common Stock outstanding as of March 16, 2023, as reported by Issuer.</div>
                </td>
              </tr>

          </table>
        </div>
      </div>
      <div><br>
      </div>
      <div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
        <div class="BRPFPageBreak" style="page-break-after: always;">
          <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
        <div style="width: 100%;" class="BRPFPageHeader">
          <div>
            <table cellspacing="0" cellpadding="0" border="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; border-collapse: collapse; text-align: left; color: #000000;">

                <tr>
                  <td style="width: 40%; vertical-align: middle; border-width: 2px; border-style: solid; border-color: rgb(0, 0, 0);">
                    <div style="text-align: center; color: #000000; font-weight: bold;">CUSIP No. 29102Y101</div>
                  </td>
                  <td style="width: 40%; vertical-align: middle; padding-bottom: 2px;">
                    <div style="text-align: justify; color: #000000;">&#160;</div>
                  </td>
                  <td style="width: 20%; vertical-align: middle; padding-bottom: 2px;">
                    <div style="color: rgb(0, 0, 0); font-weight: bold;">Page <font class="BRPFPageNumber">3</font> of 6<br>
                    </div>
                  </td>
                </tr>

            </table>
          </div>
        </div>
      </div>
      <table cellspacing="0" cellpadding="0" id="ze0f20fa495274ab78edac5ec21029e2b" class="DSPFListTable" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

          <tr>
            <td style="width: 36pt; vertical-align: top; font-weight: bold;">Item 1.</td>
            <td style="width: auto; vertical-align: top; text-align: justify;">
              <div style="font-weight: bold;">Security and Issuer</div>
            </td>
          </tr>

      </table>
      <div style="text-align: justify;"> <br>
      </div>
      <div style="text-indent: 35.65pt; margin-right: 0.35pt; margin-left: 0.7pt; color: #000000;">This Amendment No. 8 (&#8220;Amendment No. 8&#8221;) to Schedule 13D amends and supplements the Schedule 13D filed with the Securities and Exchange Commission (the
        &#8220;SEC&#8221;) on January 30, 2018, as amended by Amendment No. 1 thereto filed with the SEC on March 5, 2018, Amendment No. 2 thereto filed with the SEC on November 2, 2018, Amendment No. 3 thereto filed with the SEC on February 4, 2019,Amendment No. 4
        thereto filed with the SEC on April 1, 2019, Amendment No. 5 thereto filed with the SEC on December 20, 2019, Amendment No. 6 thereto filed with the SEC on August 17, 2020, and Amendment No. 7 thereto filed with the SEC on January 31, 2022 (as
        amended, the &#8220;Schedule 13D&#8221;), relating to the shares of common stock, $0.001 par value per share (&#8220;Common Stock&#8221;), of Skye Bioscience, Inc., a Nevada corporation formerly known as Emerald Bioscience, Inc. (the &#8220;Issuer&#8221;).The principal executive
        offices of the Issuer are located at 11250 El Camino Real, Suite 100, San Diego, CA 92130. Except as amended and supplemented hereby, the Schedule 13D remains in full force and effect. All capitalized terms not otherwise defined in this Amendment
        No. 8 shall have the same meanings ascribed thereto in the Schedule 13D.</div>
      <div style="text-align: justify;"> <br>
      </div>
      <table cellspacing="0" cellpadding="0" id="zaaa73c6d3d95468f866d151602ad2bae" class="DSPFListTable" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

          <tr>
            <td style="width: 36pt; vertical-align: top; font-weight: bold;">Item 2.</td>
            <td style="width: auto; vertical-align: top; text-align: justify;">
              <div style="font-weight: bold;">Identity and Background</div>
            </td>
          </tr>

      </table>
      <div style="text-align: justify;"> <br>
      </div>
      <div style="text-indent: 35.65pt; margin-right: 0.35pt; margin-left: 0.7pt; color: #000000;">(a) This Amendment No. 8 to Schedule 13D is being filed by Emerald Health Sciences Inc. (the &#8220;Reporting Person&#8221;).</div>
      <div style="text-align: justify;"> <br>
      </div>
      <div style="text-indent: 35.65pt; margin-right: 0.35pt; margin-left: 0.7pt; color: #000000;">(b) The business address of the Reporting Person is 10th Floor, 595 Howe St., Vancouver, BC V6C 2T5, Canada.</div>
      <div style="text-align: justify;"> <br>
      </div>
      <div style="text-indent: 35.65pt; margin-right: 0.35pt; margin-left: 0.7pt; color: #000000;">(c) The principal business of the Reporting Person is investments that advance the development of cannabis in pharmaceutical, botanical, and bioceutical
        applications.</div>
      <div style="text-align: justify;"> <br>
      </div>
      <div style="text-indent: 35.65pt; margin-right: 0.35pt; margin-left: 0.7pt; color: #000000;">(d) During the last five years the Reporting Person has not been convicted in a criminal proceeding (excluding traffic violations or similar misdemeanors).</div>
      <div style="text-align: justify;"> <br>
      </div>
      <div style="text-indent: 35.65pt; margin-right: 0.35pt; margin-left: 0.7pt; color: #000000;">(e) During the last five years the Reporting Person was not a party to a civil proceeding of a judicial or administrative body of competent jurisdiction and
        as a result of such proceeding was or is subject to a judgment, decree, or final order enjoining future violations of, or prohibiting or mandating activities subject to, federal or state securities laws, or finding any violation with respect to
        such laws.</div>
      <div style="text-align: justify;"> <br>
      </div>
      <div style="text-indent: 35.65pt; margin-right: 0.35pt; margin-left: 0.7pt; color: #000000;">(f) The Reporting Person was incorporated under the laws of British Columbia, Canada.</div>
      <div style="text-align: justify;"> <br>
      </div>
      <table cellspacing="0" cellpadding="0" id="zaa4d779208584e64ba42d6514e63ec76" class="DSPFListTable" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

          <tr>
            <td style="width: 36pt; vertical-align: top; font-weight: bold;">Item 3.</td>
            <td style="width: auto; vertical-align: top; text-align: justify;">
              <div style="font-weight: bold;">Source and Amount of Funds or Other Consideration</div>
            </td>
          </tr>

      </table>
      <div style="text-align: justify;"> <br>
      </div>
      <div style="text-indent: 35.65pt; margin-right: 0.35pt; margin-left: 0.7pt; color: #000000;">The Reporting Person used working capital to acquire warrants to purchase common stock in Emerald Health Therapeutics (&#8220;Emerald Warrants&#8221;) as described in
        Item 4. Emerald Warrants were exchanged as consideration for the Issuer warrants.</div>
      <div><br>
      </div>
      <div style="text-indent: 35.65pt; margin-right: 0.7pt; margin-left: 1.05pt; color: #000000;">The consideration for the common stock acquisition, as more fully described in Item 4, was a reduction in debt the Issuer owed to the Reporting Person.</div>
      <div style="text-indent: 35.65pt; margin-right: 0.7pt; margin-left: 1.05pt; color: #000000;"> <br>
      </div>
      <div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
        <div class="BRPFPageBreak" style="page-break-after: always;">
          <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
        <div style="width: 100%;" class="BRPFPageHeader">
          <div>
            <table cellspacing="0" cellpadding="0" border="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; border-collapse: collapse; text-align: left; color: #000000;">

                <tr>
                  <td style="width: 40%; vertical-align: middle; border-width: 2px; border-style: solid; border-color: rgb(0, 0, 0);">
                    <div style="text-align: center; color: #000000; font-weight: bold;">CUSIP No. 29102Y101</div>
                  </td>
                  <td style="width: 40%; vertical-align: middle; padding-bottom: 2px;">
                    <div style="text-align: justify; color: #000000;">&#160;</div>
                  </td>
                  <td style="width: 20%; vertical-align: middle; padding-bottom: 2px;">
                    <div style="color: rgb(0, 0, 0); font-weight: bold;">Page <font class="BRPFPageNumber">4</font> of 6<br>
                    </div>
                  </td>
                </tr>

            </table>
          </div>
        </div>
      </div>
      <table cellspacing="0" cellpadding="0" id="zf605d1c3939f414d994bae9d263a0182" class="DSPFListTable" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

          <tr>
            <td style="width: 36pt; vertical-align: top; font-weight: bold;">
              <div>Item 4.</div>
            </td>
            <td style="width: auto; vertical-align: top; text-align: justify;">
              <div style="font-weight: bold;">Purpose of the Transaction</div>
            </td>
          </tr>

      </table>
      <div style="text-align: justify;"> <br>
      </div>
      <div style="text-align: justify; text-indent: 36pt; margin-right: 0.7pt; font-weight: bold;">Acquisition of Issuer Warrants.</div>
      <div><br>
      </div>
      <div style="text-indent: 35.65pt; margin-left: 0.35pt; color: #000000;">Pursuant to the terms of an Arrangement Agreement dated May 11, 2022, as amended June 14, 2022 and July 15, 2022 (&#8220;Arrangement Agreement&#8221;) between Issuer and Emerald Health
        Therapeutics (&#8220;Emerald&#8221;), Emerald warrants were exercisable to purchase Issuer common shares with the number of shares underlying each such warrant (and the exercise price of such warrant) adjusted based on an exchange ratio of 1.95:1 (the
        &#8220;Exchange&#8221;). The Arrangement was effective November 10, 2022, and the Reporting Person acquired warrants to purchase 9,141,486 shares of Issuer Common Stock.</div>
      <div><br>
      </div>
      <div style="text-indent: 35.65pt; margin-right: 0.35pt; margin-left: 0.7pt; color: #000000; font-weight: bold;">Acquisition of Issuer Common Stock.</div>
      <div><br>
      </div>
      <div style="text-indent: 35.65pt; margin-right: 0.35pt; margin-left: 0.35pt; color: #000000;">Pursuant to the terms of a master transaction agreement dated February 16, 2023 by and between Issuer and the Reporting Person (the "MTA"), the Reporting
        Person agreed to exercise 16,641,486 warrants to purchase Issuer common stock (the "Warrants"). Under the MTA, the parties agreed that the aggregate exercise price for the Warrants of $282,905 was to be paid through a reduction in the debt owed by
        the Issuer to the Reporting Person (the "Credit Consideration") under the Credit Agreement. On February 22, 2023, the Company issued 16,641,486 shares of common stock to the Reporting Person in connection with the exercise of the Warrants.</div>
      <div><br>
      </div>
      <div style="text-indent: 35.65pt; margin-right: 0.35pt; margin-left: 0.35pt; color: #000000;">Pursuant to the terms of the MTA, after the application of the Credit Consideration to the amounts owed under the Credit Agreement, the Reporting Person
        agreed to convert the remaining balance of $1,597,236 owed by the Issuer to the Reporting Person under the Credit Agreement into 41,379,164 shares of common stock of the Issuer at a conversion price of $0.0386, in accordance with an amendment to
        the Credit Agreement set forth in the MTA.</div>
      <div><br>
      </div>
      <div style="text-indent: 35.65pt; margin-right: 0.35pt; margin-left: 0.35pt; color: #000000;">Following the issuance of shares described above, the Credit Agreement was terminated in its entirety per the terms of the MTA.</div>
      <div><br>
      </div>
      <div style="text-indent: 35.65pt; margin-right: 0.35pt; margin-left: 0.35pt; color: #000000;">Additionally, under the MTA, the Reporting Person agreed to use its best efforts to transfer all of the common stock of the Issuer held by the Reporting
        Person to its shareholders on a pro-rata basis at or immediately prior to the Issuer&#8217;s listing to a nationally recognized stock exchange, subject to compliance with applicable securities laws.</div>
      <div><br>
      </div>
      <div style="text-indent: 35.65pt; margin-right: 0.35pt; margin-left: 0.35pt; color: #000000;">The foregoing summary of the MTA is qualified in its entirety by reference to the full text of the MTA, a copy of which was filed as Exhibit 10.1 to the
        Issuer&#8217;s Form 8-K filed with the SEC on February 23, 2023, and incorporated herein by reference.</div>
      <div><br>
      </div>
      <div style="text-indent: 35.65pt; margin-right: 0.35pt; margin-left: 0.7pt; color: #000000;">Subject to ongoing evaluation, except as set forth above, the Reporting Person has no current plans or proposals which relate to or would result in any of
        the following:</div>
      <div style="text-align: justify;"> <br>
      </div>
      <div style="text-indent: 35.65pt; margin-right: 0.35pt; margin-left: 0.7pt; color: #000000;">(a) The acquisition by any person of additional securities of the Issuer, or the disposition of securities of the Issuer;</div>
      <div style="text-align: justify;"> <br>
      </div>
      <div style="text-indent: 35.65pt; margin-right: 0.35pt; margin-left: 0.7pt; color: #000000;">(b) An extraordinary corporate transaction, such as a merger, reorganization, or liquidation, involving the Issuer or any of its subsidiaries;</div>
      <div style="text-align: justify;"> <br>
      </div>
      <div style="text-indent: 35.65pt; margin-right: 0.35pt; margin-left: 0.7pt; color: #000000;">(c) A sale or transfer of a material amount of assets of the Issuer or any of its subsidiaries;</div>
      <div style="text-align: justify;"> <br>
      </div>
      <div style="text-indent: 35.65pt; margin-right: 0.35pt; margin-left: 0.7pt; color: #000000;">(d) Any change in the present board of directors or management of the Issuer, including any plans or proposals to change the number or term of directors or
        to fill any existing vacancies on the board;</div>
      <div style="text-align: justify;"> <br>
      </div>
      <div style="text-indent: 35.65pt; margin-right: 0.7pt; margin-left: 1.05pt; color: #000000;">(e) Any material change in the present capitalization or dividend policy of the Issuer;</div>
      <div style="text-indent: 35.65pt; margin-right: 0.7pt; margin-left: 1.05pt; color: #000000;"> <br>
      </div>
      <div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
        <div class="BRPFPageBreak" style="page-break-after: always;">
          <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
        <div style="width: 100%;" class="BRPFPageHeader">
          <div>
            <table cellspacing="0" cellpadding="0" border="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; border-collapse: collapse; text-align: left; color: #000000;">

                <tr>
                  <td style="width: 40%; vertical-align: middle; border-width: 2px; border-style: solid; border-color: rgb(0, 0, 0);">
                    <div style="text-align: center; color: #000000; font-weight: bold;">CUSIP No. 29102Y101</div>
                  </td>
                  <td style="width: 40%; vertical-align: middle; padding-bottom: 2px;">
                    <div style="text-align: justify; color: #000000;">&#160;</div>
                  </td>
                  <td style="width: 20%; vertical-align: middle; padding-bottom: 2px;">
                    <div style="color: rgb(0, 0, 0); font-weight: bold;">Page <font class="BRPFPageNumber">5</font> of 6<br>
                    </div>
                  </td>
                </tr>

            </table>
          </div>
        </div>
      </div>
      <div style="text-indent: 35.65pt; margin-right: 0.35pt; margin-left: 0.7pt; color: #000000;">(f) Any other material change in the Issuer&#8217;s business or corporate structure, including but not limited to, if the Issuer is a registered closed-end
        investment company, any plans or proposals to make any changes in its investment policy for which a vote is required by Section 13 of the Investment Company Act of 1940;</div>
      <div style="text-align: justify;"> <br>
      </div>
      <div style="text-indent: 35.65pt; margin-right: 0.35pt; margin-left: 0.7pt; color: #000000;">(g) Changes in the Issuer&#8217;s charter, bylaws, or instruments corresponding thereto or other actions which may impede the acquisition of control of the issuer
        by any person;</div>
      <div style="text-align: justify;"> <br>
      </div>
      <div style="text-indent: 35.65pt; margin-right: 0.35pt; margin-left: 0.7pt; color: #000000;">(h) Causing a class of securities of the Issuer to be delisted from a national securities exchange or to cease to be authorized to be quoted in an
        inter-dealer quotation system of a registered national securities association;</div>
      <div style="text-align: justify;"> <br>
      </div>
      <div style="text-indent: 35.65pt; margin-right: 0.35pt; margin-left: 0.7pt; color: #000000;">(i) A class of equity securities of the Issuer becoming eligible for termination of registration pursuant to Section 12(g)(4) of the Act; or</div>
      <div style="text-align: justify;"> <br>
      </div>
      <div style="text-indent: 35.65pt; margin-right: 0.35pt; margin-left: 0.7pt; color: #000000;">(j) Any action similar to any of those enumerated above.</div>
      <div style="text-align: justify;"> <br>
      </div>
      <table cellspacing="0" cellpadding="0" id="zafee4aa167204fc3bef73e8aa7d40de3" class="DSPFListTable" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

          <tr>
            <td style="width: 36pt; vertical-align: top; font-weight: bold;">Item 5.</td>
            <td style="width: auto; vertical-align: top; text-align: justify;">
              <div style="font-weight: bold;">Interest in Securities of the Issuer</div>
            </td>
          </tr>

      </table>
      <div style="text-align: justify;"> <br>
      </div>
      <div style="text-indent: 35.65pt; margin-right: 0.35pt; margin-left: 0.7pt; color: #000000;">(a) The Reporting Person beneficially owns 169,407,901 shares of Common Stock, which represents approximately 17.4% of the outstanding shares of Common
        Stock.</div>
      <div style="text-align: justify;"> <br>
      </div>
      <div style="text-indent: 35.65pt; margin-right: 0.35pt; margin-left: 0.7pt; color: #000000;">(b) The Reporting Person has the sole power to vote and sole power to dispose of 169,407,901 shares of Common Stock, which represent approximately 18% of the
        outstanding shares of Common Stock.</div>
      <div style="text-align: justify;"> <br>
      </div>
      <div style="text-indent: 35.65pt; margin-right: 0.35pt; margin-left: 0.7pt; color: #000000;">(c) No transactions in the Issuer&#8217;s Common Stock were effected during the past 60 days by the Reporting Person except as set forth in Item 3 above.</div>
      <div style="text-align: justify;"> <br>
      </div>
      <div style="text-indent: 35.65pt; margin-right: 0.35pt; margin-left: 0.7pt; color: #000000;">(d) Not applicable.</div>
      <div style="text-align: justify;"> <br>
      </div>
      <div style="text-indent: 35.65pt; margin-right: 0.35pt; margin-left: 0.7pt; color: #000000;">(e) Not applicable.</div>
      <div style="text-align: justify;"> <br>
      </div>
      <table cellspacing="0" cellpadding="0" id="z48ffdaf55bba41659869631231f34044" class="DSPFListTable" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

          <tr>
            <td style="width: 36pt; vertical-align: top; font-weight: bold;">Item 6.</td>
            <td style="width: auto; vertical-align: top; text-align: justify;">
              <div style="font-weight: bold;">Contracts, Arrangements, Understandings or Relationships with Respect to Securities of the Issuer</div>
            </td>
          </tr>

      </table>
      <div style="text-align: justify;"> <br>
      </div>
      <div style="text-indent: 35.65pt; margin-right: 0.35pt; margin-left: 0.7pt; color: #000000;">The information set forth in item 4 above is incorporated herein by reference.&#160; Pursuant to the MTA, the Reporting Person will use its best efforts to
        transfer all of the common stock of the Issuer held by the Reporting Person to its shareholders on a pro-rata basis at or immediately prior to the Issuer&#8217;s listing to a nationally recognized stock exchange, subject to compliance with applicable
        securities laws.</div>
      <div style="text-align: justify; text-indent: 33.75pt;"> <br>
      </div>
      <table cellspacing="0" cellpadding="0" id="z69899828aa84471ba4d2dc9a7651a262" class="DSPFListTable" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

          <tr>
            <td style="width: 36pt; vertical-align: top; font-weight: bold;">Item 7.</td>
            <td style="width: auto; vertical-align: top; text-align: justify;">
              <div style="font-weight: bold;">Material to be Filed as Exhibits</div>
            </td>
          </tr>

      </table>
      <div style="text-align: justify;"> <br>
      </div>
      <div style="text-indent: 35.65pt; margin-right: 0.7pt; margin-left: 1.05pt;"><font style="color: #000000;">Exhibit 10.1 &#8211; Master Transaction Agreement, dated February 16, 2023, by and between the Issuer and Reporting Person (incorporated herein by
          reference to Exhibit 10.1 to the Issuer&#8217;s Current Report on Form 8-K filed with the Commission on February 23, 2023, File No. </font><font style="color: #373739;">000-55136</font><font style="color: #000000;">).</font></div>
      <div><br>
      </div>
      <div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
        <div class="BRPFPageBreak" style="page-break-after: always;">
          <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
        <div style="width: 100%;" class="BRPFPageHeader">
          <div>
            <table cellspacing="0" cellpadding="0" border="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; border-collapse: collapse; text-align: left; color: #000000;">

                <tr>
                  <td style="width: 40%; vertical-align: middle; border-width: 2px; border-style: solid; border-color: rgb(0, 0, 0);">
                    <div style="text-align: center; color: #000000; font-weight: bold;">CUSIP No. 29102Y101</div>
                  </td>
                  <td style="width: 40%; vertical-align: middle; padding-bottom: 2px;">
                    <div style="text-align: justify; color: #000000;">&#160;</div>
                  </td>
                  <td style="width: 20%; vertical-align: middle; padding-bottom: 2px;">
                    <div style="color: rgb(0, 0, 0); font-weight: bold;">Page <font class="BRPFPageNumber">6</font> of 6<br>
                    </div>
                  </td>
                </tr>

            </table>
          </div>
        </div>
      </div>
      <div style="text-align: center; font-weight: bold;">SIGNATURE</div>
      <div style="text-align: justify;"> <br>
      </div>
      <div style="text-indent: 35.65pt; margin-right: 0.35pt; margin-left: 0.7pt; color: #000000;">After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true,&#160; complete, and
        correct.</div>
      <div style="text-align: justify;"> <br>
      </div>
      <table cellspacing="0" cellpadding="0" border="0" id="zcee1e310d8cb4e9faa8cc44cd957a0ee" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; border-collapse: collapse; text-align: left; color: #000000;">

          <tr>
            <td style="width: 50%; vertical-align: middle;"><br>
            </td>
            <td style="vertical-align: middle;" colspan="2">
              <div style="color: rgb(0, 0, 0); font-weight: bold;">EMERALD HEALTH SCIENCES INC.</div>
            </td>
          </tr>
          <tr>
            <td style="width: 50%; vertical-align: middle;"><br>
            </td>
            <td style="width: 3%; vertical-align: middle;"><br>
            </td>
            <td style="vertical-align: middle; width: 47%;"><br>
            </td>
          </tr>
          <tr>
            <td style="width: 50%; vertical-align: middle; padding-bottom: 2px;">
              <div style="color: rgb(0, 0, 0);">Dated:&#160; March 16, 2023</div>
            </td>
            <td style="width: 3%; vertical-align: middle; padding-bottom: 2px;">
              <div style="color: rgb(0, 0, 0);">By:</div>
            </td>
            <td style="width: 47%; vertical-align: middle; border-bottom: 2px solid rgb(0, 0, 0);" rowspan="1">
              <div><font style="font-style: italic; color: #000000;">/s/ Stephen Hall</font><br>
              </div>
            </td>
          </tr>
          <tr>
            <td style="width: 50%; vertical-align: middle;"><br>
            </td>
            <td style="width: 3%; vertical-align: middle;"><br>
            </td>
            <td style="vertical-align: middle; width: 47%;">
              <div style="color: rgb(0, 0, 0);">Stephen Hall,</div>
            </td>
          </tr>
          <tr>
            <td style="width: 50%; vertical-align: middle;"><br>
            </td>
            <td style="width: 3%; vertical-align: middle;"><br>
            </td>
            <td style="vertical-align: middle; width: 47%;">
              <div style="color: rgb(0, 0, 0);">Chief Financial Officer</div>
            </td>
          </tr>

      </table>
      <div style="text-align: justify;"> <br>
      </div>
      <div style="text-align: justify;"> <br>
      </div>
      <div>
        <hr noshade="noshade" align="center" style="height: 2px; color: #000000; background-color: #000000; text-align: center; margin-left: auto; margin-right: auto; border: none;"></div>
    </div>
  </div>
</body>
</html>
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
